Kestra Medical Technologies (NASDAQ:KMTS) CFO Vaseem Mahboob Sells 4,788 Shares of Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) CFO Vaseem Mahboob sold 4,788 shares of the company’s stock in a transaction on Thursday, October 29th. The stock was sold at an average price of $30.60, for a total transaction of $146,512.80. Following the sale, the chief financial officer directly owned 60,609 shares of the company’s stock, valued at approximately $1,854,635.40. This trade represents a 7.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.

Vaseem Mahboob also recently made the following trade(s):

• On Tuesday, October 27th, Vaseem Mahboob sold 34,809 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $30.04, for a total value of $1,045,662.36.
• On Wednesday, October 28th, Vaseem Mahboob sold 39,903 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $30.48, for a total value of $1,216,243.44.
• On Friday, August 7th, Vaseem Mahboob sold 26,287 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $25.88, for a total transaction of $680,307.56.
• On Tuesday, August 4th, Vaseem Mahboob sold 6,995 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $24.68, for a total transaction of $172,636.60.
• On Monday, August 3rd, Vaseem Mahboob sold 5,391 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.80, for a total transaction of $128,305.80.
• On Friday, July 31st, Vaseem Mahboob sold 8,817 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.61, for a total value of $199,352.37.

Kestra Medical Technologies Stock Up 2.5%

Shares of NASDAQ:KMTS traded up $0.74 during trading on Thursday, hitting $30.61. The company’s stock had a trading volume of 470,598 shares, compared to its average volume of 351,886. The company has a market capitalization of $1.82 billion, a PE ratio of -11.46 and a beta of 0.51. Kestra Medical Technologies, Ltd. has a fifty-two week low of $17.34 and a fifty-two week high of $31.04. The company has a debt-to-equity ratio of 0.33, a quick ratio of 4.69 and a current ratio of 4.69. The stock’s 50-day moving average price is $26.59 and its two-hundred day moving average price is $23.76.

Kestra Medical Technologies (NASDAQ:KMTS) last issued its quarterly earnings data on Monday, September 14th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.14). Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. The business had revenue of $30.97 million for the quarter. As a group, sell-side analysts expect that Kestra Medical Technologies, Ltd. will post -2.45 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Sterling Capital Management LLC grew its position in shares of Kestra Medical Technologies by 834.0% during the 3rd quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after buying an additional 784 shares during the last quarter. The Manufacturers Life Insurance Company lifted its holdings in Kestra Medical Technologies by 6.6% in the first quarter. The Manufacturers Life Insurance Company now owns 92,515 shares of the company’s stock worth $1,844,000 after acquiring an additional 5,731 shares during the last quarter. California State Teachers Retirement System lifted its holdings in Kestra Medical Technologies by 39.2% in the first quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock worth $555,000 after acquiring an additional 7,844 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Kestra Medical Technologies in the third quarter worth about $353,000. Finally, Quantinno Capital Management LP acquired a new position in Kestra Medical Technologies in the first quarter valued at approximately $431,000.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on KMTS shares. BTIG Research reissued a “buy” rating and set a $32.00 price objective on shares of Kestra Medical Technologies in a report on Tuesday, September 15th. Piper Sandler restated an “overweight” rating on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Weiss Ratings upgraded Kestra Medical Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, September 16th. Royal Bank Of Canada set a $30.00 price target on Kestra Medical Technologies in a research note on Tuesday, September 15th. Finally, JPMorgan Chase & Co. assumed coverage on Kestra Medical Technologies in a research note on Monday, August 10th. They set an “overweight” rating and a $30.00 price objective on the stock. Five investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $29.00.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.